These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31037491)

  • 21. Serpiginous choroiditis-like picture due to ocular toxoplasmosis.
    Mahendradas P; Kamath G; Mahalakshmi B; Shetty KB
    Ocul Immunol Inflamm; 2007; 15(2):127-30. PubMed ID: 17558839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ophthalmological findings in children with congenital toxoplasmosis. Report from a Swedish prospective screening study of congenital toxoplasmosis with two years of follow-up.
    Fahnehjelm KT; Malm G; Ygge J; Engman ML; Maly E; Evengård B
    Acta Ophthalmol Scand; 2000 Oct; 78(5):569-75. PubMed ID: 11037917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of drug therapy on the risk of recurrence of ocular toxoplasmosis.
    Reich M; Becker MD; Mackensen F
    Br J Ophthalmol; 2016 Feb; 100(2):195-9. PubMed ID: 26163541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 30-2 Standard and Fast programs of Swedish Interactive Threshold Algorithm of Humphrey Field Analyzer for perimetry in patients with intracranial tumors.
    Singh MD; Jain K
    Indian J Ophthalmol; 2017 Nov; 65(11):1198-1202. PubMed ID: 29133651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of two Humphrey perimetry programs: full threshold and SITA standard testing strategy for learning effect.
    Yenice O; Temel A
    Eur J Ophthalmol; 2005; 15(2):209-12. PubMed ID: 15812761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectral optical coherence tomography findings in patients with ocular toxoplasmosis and active satellite lesions (MINAS Report 1).
    Oréfice JL; Costa RA; Scott IU; Calucci D; Oréfice F;
    Acta Ophthalmol; 2013 Feb; 91(1):e41-7. PubMed ID: 22970804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ocular impairment of toxoplasmosis.
    Antoniazzi E; Guagliano R; Meroni V; Pezzotta S; Bianchi PE
    Parassitologia; 2008 Jun; 50(1-2):35-6. PubMed ID: 18693554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxoplasmic Retinochoroiditis: Clinical Characteristics and Visual Outcome in a Prospective Study.
    Aleixo AL; Curi AL; Benchimol EI; Amendoeira MR
    PLoS Negl Trop Dis; 2016 May; 10(5):e0004685. PubMed ID: 27136081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pattern of ocular toxoplasmosis treated in a referral centre in Serbia.
    Kovačević-Pavićević D; Radosavljević A; Ilić A; Kovačević I; Djurković-Djaković O
    Eye (Lond); 2012 May; 26(5):723-8. PubMed ID: 22361847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasma serotype is associated with development of ocular toxoplasmosis.
    Shobab L; Pleyer U; Johnsen J; Metzner S; James ER; Torun N; Fay MP; Liesenfeld O; Grigg ME
    J Infect Dis; 2013 Nov; 208(9):1520-8. PubMed ID: 23878321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of the Amsler Grid Test in Evaluating Glaucomatous Central Visual Field Defects.
    Su D; Greenberg A; Simonson JL; Teng CC; Liebmann JM; Ritch R; Park SC
    Ophthalmology; 2016 Apr; 123(4):737-43. PubMed ID: 26783097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of Toxoplasma gondii in aqueous humour by the polymerase chain reaction.
    Aouizerate F; Cazenave J; Poirier L; Verin P; Cheyrou A; Begueret J; Lagoutte F
    Br J Ophthalmol; 1993 Feb; 77(2):107-9. PubMed ID: 8435409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactivation of ocular toxoplasmosis in fellow unaffected eye.
    Seng Lee M; Boyce RL; Clarke JR
    Eur J Ophthalmol; 2004; 14(4):338-40. PubMed ID: 15309981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results.
    Leleu I; Penaud B; Blumen-Ohana E; Rodallec T; Adam R; Laplace O; Akesbi J; Nordmann JP
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1489-1498. PubMed ID: 29862428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute iridocyclitis in a patient with AIDS diagnosed as toxoplasmosis by PCR.
    Cano-Parra JL; Díaz-LLopis ML; Cordoba JL; Gobernado ML; Navea AL; Menezo JL
    Ocul Immunol Inflamm; 2000 Jun; 8(2):127-30. PubMed ID: 10980687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular Toxocariasis: Clinical Features and Long-term Visual Outcomes in Adult Patients.
    Despreaux R; Fardeau C; Touhami S; Brasnu E; Champion E; Paris L; Touitou V; Bodaghi B; Lehoang P
    Am J Ophthalmol; 2016 Jun; 166():162-168. PubMed ID: 27066722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of immunoblotting, calculation of the Goldmann-Witmer coefficient, and real-time PCR using aqueous humor samples for diagnosis of ocular toxoplasmosis.
    Fekkar A; Bodaghi B; Touafek F; Le Hoang P; Mazier D; Paris L
    J Clin Microbiol; 2008 Jun; 46(6):1965-7. PubMed ID: 18400917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of iPad-based threshold perimetry in glaucoma and controls.
    Schulz AM; Graham EC; You Y; Klistorner A; Graham SL
    Clin Exp Ophthalmol; 2018 May; 46(4):346-355. PubMed ID: 28976067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reproducibility in the global indices for multifocal visual evoked potentials and Humphrey visual fields in controls and glaucomatous eyes within a 2-year period.
    Inoue Y; Kato K; Kamata S; Ishikawa K; Nakamura M
    Doc Ophthalmol; 2015 Oct; 131(2):115-24. PubMed ID: 26078041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fulminant Ocular Toxoplasmosis: The Hazards of Corticosteroid Monotherapy.
    Oray M; Ozdal PC; Cebeci Z; Kir N; Tugal-Tutkun I
    Ocul Immunol Inflamm; 2016 Dec; 24(6):637-646. PubMed ID: 26647176
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.